Drug Shortage Report for ALMOTRIPTAN
| Report ID | 14180 |
| Drug Identification Number | 02424029 |
| Brand name | ALMOTRIPTAN |
| Common or Proper name | ALMOTRIPTAN |
| Company Name | PRO DOC LIMITEE |
| Market Status | MARKETED |
| Active Ingredient(s) | ALMOTRIPTAN |
| Strength(s) | 12.5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 6 |
| ATC code | N02CC |
| ATC description | ANTIMIGRAINE PREPARATIONS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2018-11-23 |
| Estimated end date | |
| Actual end date | 2018-12-21 |
| Shortage status | Resolved |
| Updated date | 2018-12-22 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
| Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.